Back to search
PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE
Clinical trial pipeline · Data from ClinicalTrials.gov
See which PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE trials you may qualify forThe goal of this clinical trial is to learn if whole-cell Streptococcus pneumoniae (wSp) vaccination is safe and tolerated in healthy adults. The main aim is to…
As the licensed Pneumovax 23™ vaccine is not always satisfactory in elderly subjects, the safety and the immune response of the new investigational pneumococcal…
As the licensed pneumococcal vaccine is not always satisfactory in elderly, new investigational pneumococcal vaccines are evaluated in the healthy elderly popul…
This study is to describe the safety and immunogenicity of 13vPnC in Indian adults 50 to 65 years of age and in Indian children 6 to 17 years of age.
The purpose of this study is to evaluate the immunogenicity and safety of 13-valent pneumococcal polysaccharide vaccine when given concomitantly with seasonal i…
The purpose of this study is to assess the efficacy of 13-valent pneumococcal conjugate vaccine in the prevention of the first episode of vaccine-type pneumococ…
The aim of this study is to evaluate the postlicensure effectiveness of Prevnar in the prevention of IPD in the Spanish paediatric population (children younger…